Aproximaciones para manipular el genoma
https://acnp.org/wp-content/uploads/2017/11/CH19_241-252.pdf
https://www.sap.org.ar/docs/publicaciones/archivosarg/2010/v108n5a10.pdf
Metzger D, Chambon P. Site- and time-specific gene targeting in the mouse.Methods. 2001;24(1):71-80. doi:10.1006/meth.2001.1159
Manis JP. Knock out, knock in, knock down--genetically manipulated mice and the Nobel Prize.N Engl J Med. 2007;357(24):2426-2429. doi:10.1056/NEJMp0707712
LePage DF, Conlon RA. Animal models for disease: knockout, knock-in, and conditional mutant mice.Methods Mol Med. 2006;129:41-67. doi:10.1385/1-59745-213-0:41
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.Science. 2012;337(6096):816-821. doi:10.1126/science.1225829
Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system.Nat Protoc. 2013;8(11):2281-2308. doi:10.1038/nprot.2013.143
Mojica FJM, Montoliu L. On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals.Trends Microbiol. 2016;24(10):811-820. doi:10.1016/j.tim.2016.06.005
Charpentier E, Doudna JA. Biotechnology: Rewriting a genome.Nature. 2013;495(7439):50-51. doi:10.1038/495050a
Knott GJ, Doudna JA. CRISPR-Cas guides the future of genetic engineering.Science. 2018;361(6405):866-869. doi:10.1126/science.aat5011
El pez cebra en investigación:
Directiva 2003/65/CE del Parlamento Europeo y del Consejo, de 22 de Julio de 2003, disposiciones legales, reglamentarias y administrativas de los Estados miembros respecto a la protección de los animales utilizados para experimentos y otros fines científicos.
Convenio Europeo sobre protección de los animales vertebrados utilizados con fines experimentales y otros fines científicos firmado en Estrasburgo (Francia) el 18 de marzo de 1986.
Directiva 2010/63/UE del Parlamento Europeo y del Consejo, de 22 de septiembre de 2010 relativa a la protección de los animales utilizados para fines científicos.
Real Decreto 53/2013, de 1 de febrero, por el que se establecen las normas básicas aplicables para la protección de los animales utilizados en experimentación y otros fines científicos, incluyendo la docencia.
Nüsslein-Volhard, C. and Dahm R. (2002). Zebrafish , A practical approach
Spence R et al. (2008). The behavior and ecology of the zebrafish, Danio rerio.
Westerfield M. (1993). The Zebrafish Book, A guide for the laboratory use of zebrafish
Westerfield M. (2007). The zebrafish book. A Guide for the Laboratory Use of Zebrafish (Danio rerio), 5th Edition. University of Oregon Press, Eugene.
Carter, K.M., Woodley, C.M., Brown, R.G. (2011) A review of tricaine methanesulfonate for anesthesia of fish. Rev. Fish Biol. Fisheries 21: 51-59.
Modelo de early- ADMETox en el descubrimiento de fármacos:
OECD (1992) Test Guideline 203. OECD Guideline for Testing of Chemicals. Fish, Acute Toxicity.
OECD (1992) Test Guideline 210. OECD Guideline for Testing of Chemicals. Fish, Early-life Stage Toxicity Test.
OECD (2012) Test Guideline 236. OECD Guideline for Testing of Chemicals. Fish Embryo Acute Toxicity (FET) Test.
Belanger, S. E., Rawlings J. M. and Carr G. J. (2013). Use of Fish Embryo Toxicity Tests for the Prediction of Acute Fish Toxicity to Chemicals. Environmental Toxicology and Chemistry, 8: 1768-83.
Lammer, E., Carr, G. J., Wendler, K., Rawlings, J. M., Belanger, S. E., Braunbeck, T. (2009). Is the fish embryo toxicity test (FET) with the zebrafish (Danio rerio) a potential alternative for the fish acute toxicity test? Comp. Biochem. Physiol. C Toxicol, 149: 196−209.
Knobel M., Basser F.J.M., Rico A.R., Kramer N.I., Hermens J.M.L. and Hafner C. (2012). Predicting adult fish acute lethality with the zebrafish embryo: relevance of test duration, endpoint, compound properties, and exposure concentration analysis. Environmental Science Technology, 46: 9690-9700.
Alfaro JM, Prades A, Ramos MC, Peris E, Ripoll-Gómez J, Poyatos M, Burgos JS. (2010). Biomedical properties of a series of ruthenium-N-heterocyclic carbene complexes based on oxidant activity in vitro and assessment in vivo of biosafety in zebrafish embryos. Zebrafish, 7: 13-21.
Yang, L., et al.( 2009). Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reproductive toxicology, 28(2): 245-53.
Zon LI and Peterson RT. (2005). In vivo drug discovery in the zebrafish. Nature Reviews Drug Discovery 4: 35-44.
Modelo de enfermedades en investigación preclínica:
Lieschke GJ and Currie PD (2007) Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 8, 353-67.
Ablain J, Durand EM, Yang S, Zhou Y, Zon LI. (2015). A CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish. Dev Cell, 32(6):756-64
Peterson, R.T., et al. (2004). Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nature biotechnology, 22(5): p. 595-9.
Asnani A, Peterson RT.(2014). The zebrafish as a tool to identify novel therapies for human cardiovascular disease. Dis Model Mech, 7(7):763-7.
Wilkinson RN, Jopling C, van Eeden FJ. (2014). Zebrafish as a model of cardiac disease. Prog Mol Biol Transl Sci, 124:65-91.
Santana S, Rico E.P, Burgos J.S. (2012). Can zebrafish be used as animal model to study Alzheimer’s disease? Am J Neurodegener. Dis., 1: 32-48.
Ramesh TM, Shaw PJ, McDearmid J. (2014). A zebrafish model exemplifies the long preclinical period of motor neuron disease. J Neurol Neurosurg Psychiatry, 85(11):1288-9.
Barriuso J, Nagaraju R, Hurlstone A. (2015). Zebrafish in oncology. Aging (Albany NY), 5:286-7.
Martin, C.S., A. Moriyama, and L.I. Zon. (2011). Hematopoietic stem cells, hematopoiesis and disease: lessons from the zebrafish model. Genome medicine, 3(12): 83.
